Diverging Views and Strategic Moves Shape BASF's Financial Landscape

BASF beats cost targets but gives cautious 2024 guidance. Analysts are divided as the company pursues asset sales and potential US tariff reimbursements.

The German chemical giant BASF finds itself at a confluence of contrasting analyst opinions and strategic financial maneuvers. Recent developments include a major property sale approval and potential tariff reimbursements, painting a complex picture for the company's near-term trajectory.

Cost Performance and Cautious Guidance

On the operational front, BASF has exceeded its initial cost-saving targets. By the end of 2025, the company achieved annual savings of approximately €1.7 billion, surpassing its goal by €100 million. Management has now raised its ambition, targeting €2.3 billion in savings by the end of 2026, an increase from the previously planned €2.1 billion.

Despite this efficiency drive, the company's outlook for the current year remains conservative. Its forecast for EBITDA before special items, with a midpoint of €6.6 billion, sits below the consensus estimate of €7.0 billion. Furthermore, foreign exchange headwinds from a weaker U.S. dollar are expected to negatively impact first-quarter results by around €200 million. Investors will gain clarity on April 30th when BASF presents its Q1 figures at the Annual Meeting in Mannheim. This report will be a key test of whether the intensified cost-cutting and price increases can offset the currency pressure and justify the share price's 13.77% gain since the start of the year.

Analyst Consensus Breaks Down

Market experts are sending mixed signals regarding BASF's equity. Goldman Sachs has reinforced its bullish stance, upgrading its price target from €61 to €63 while maintaining a Buy recommendation. In a contrasting move, Kepler Cheuvreux has adopted a more cautious view. Analyst Christian Faitz reduced the price target from €56 to €54 and downgraded the stock to a Neutral rating.

Faitz justified the downgrade by citing what he perceives as an exaggerated market hype surrounding the Middle East situation. While BASF is being traded as a potential beneficiary of the crisis, he argues the company is not fully insulated. The analyst also highlighted structural concerns, noting that rising raw material costs could pressure margins in the short term, while an increased need for working capital may temporarily shift cash flows.

Portfolio Streamlining and Potential Cash Inflows

BASF continues to advance its portfolio optimization strategy. The city of Ludwigshafen has granted approval for the sale of 4,400 company-owned apartments. The chemical group intends to use the proceeds to strengthen its balance sheet and reinvest in its core business, with an emphasis on finding a socially responsible buyer. This move follows the recently completed divestment of its optical brighteners business to Catexel, finalized at the end of February.

A separate potential liquidity event stems from the United States. A February ruling by the U.S. Supreme Court declared the blanket Trump-era tariffs unconstitutional. BASF CEO Markus Kamieth has stated the company will pursue potential reimbursement claims, joining other firms like FedEx and Costco in this effort.